Type A behavior pattern and coronary heart disease: Philip Morris's "crown jewel".
Level 5 - mechanism / opinion, no new human data
Historical document analysis of internal corporate records without clinical trial or patient cohort data
PubMed 22994187 · doi:10.2105/AJPH.2012.300816
What was done
The authors analyzed internal tobacco industry documents to investigate industry funding of Type A behavior pattern (TABP) research and how those findings were utilized in relation to coronary heart disease debates.
What was found
The abstract reports no numerical data. Qualitatively, it found that the tobacco industry was a major funder of TABP research, using selective results to challenge evidence linking tobacco to heart disease. The authors conclude that industry involvement helps explain the decline effect and subsequent inconsistencies observed in TABP epidemiological studies.
Why it matters
This study highlights how corporate funding and strategic dissemination can generate and sustain scientific hypotheses to distract from known health risks, explaining historical inconsistencies in cardiovascular behavioral research.
Limits
The abstract provides no quantitative metrics, details on the specific document archives searched, selection criteria, or the number of documents reviewed. The analysis relies on historical document interpretation rather than original epidemiological or clinical data.